Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein

EMBO Journal

Volumn 20, Issue 24, 2001, Pages 7184-7196

  Kitabayashi, Issay ^a,b   Aikawa, Yukiko ^a   Nguyen, Lan Anh ^a,b   Yokoyama, Akihiko ^a,b   Ohki, Misao ^a  

^a Cancer Genomics Project   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

AML1; Histone acetylation; Leukemia; MOZ

Indexed keywords

GENE PRODUCT; HISTONE ACETYLTRANSFERASE; HYBRID PROTEIN; PROTEIN MOZ; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CBP; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACETYLATION; ACUTE MONOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION 8; COMPLEX FORMATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; REACTION ANALYSIS; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ACETYLTRANSFERASES; AMINO ACID SEQUENCE; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CREB-BINDING PROTEIN; DNA PRIMERS; DNA-BINDING PROTEINS; HISTONE ACETYLTRANSFERASES; HUMANS; MACROPHAGES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

DNA VIRUSES;

EID: 0037126635     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.24.7184     Document Type: Article

References (46)

1. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein
2. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia
3. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22)
4. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase
5. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
6. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase
7. Structure and ligand of a histone acetyltransferase bromodomain
8. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO
9. Histone acetylation in chromatin structure and transcription
10. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription
11. Adenovirus E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13)
12. TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation
13. Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor α subunit revealed in the presence of the β subunit
14. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor α (CBFα) subunit by the leukemia-related PEBP2/CBFβ-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation
15. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1
16. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation
17. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation
18. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors
19. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of genes for MOZ and TIF2
20. Oncogenic transcription factors in human acute leukemia
21. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors
22. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia
23. The t(8;21) fusion protein interferes with AML 1B-dependent transcriptional activation
24. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor
25. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2
26. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
27. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13)
28. What's up and down with histone acetylation and transcription?
29. Chromosomal translocations in human cancer
30. Crystal structure of globular domain of histone H5 and its implications for nucleosome binding
31. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor β
32. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation
33. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates
34. A novel cofactor for p300 that regulates the p53 response
35. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)
36. Histone acetylation and transcriptional regulatory mechanisms
37. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene
38. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias
39. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
40. Histone acetylation: Chromatin in action
41. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex
42. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor
43. Disruption of the Cbfα2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis
44. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo
45. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
46. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300